Sjonnie2 schreef op 18 oktober 2019 15:14:
[...]
Dat klopt niet, op de afgelopen CHMP meeting stond Kiadis
wel op de agenda.
3.4.3. viable T-cells - Orphan - ATMP - EMEA/H/C/002397
Kiadis Pharma Netherlands B.V.; adjunctive treatment in haematopoietic stem cell
transplantation (HSCT) for a malignant disease
Scope: Update on the CAT discussions at their October meeting
Action: For discussion
List of Outstanding Issues adopted on 21.06.2019, 14.09.2018, 25.05.2018. List of Questions
adopted on 08.09.2017.
www.ema.europa.eu/en/documents/agenda...